Mail & Guardian
Mail & Guardian
medicines patent poollatest news & developments
To end Aids by 2043, the South African government says it could get a group of local pharmaceutical companies to make generic shots of lenacapavir from 2027 onwards. There is, however, a hitch. None of the companies that will be involved have a licence to make the jab. (Julia Koblitz/ Unsplash)
AARON MOTSOALEDI

SA wants to make its own six-monthly HIV prevention jabs by 2027. But there’s a hitch

None of the companies that will be involved have a licence from the inventor of Lenacapavir, Gilead Sciences, to make the jab

  • Mia Malan
9 min read
AFRICA

Sharing the secrets of making a Covid-19 vaccine isn’t enough. Here’s why

For all the excitement generated by the news of an mRNA vaccine hub being established in South Africa, the country is still going to need help making Covid-19 jabs

  • Adèle Sulcas
  • Mia Malan
10 min read